MedTrace Logo

PACE4 in Thyroid Cancer

NCT03160482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2018-10-02

No results posted yet for this study

Summary

The investigation of thyroid nodules is limited by the fact that up to 49% of the fine needle aspirations (FNA) performed are of "indeterminate cytological signification". Moreover, no fully reliable molecular marker for thyroid cancer have been described. The goal of this project is to study the expression of a specific kind of protein convertase in benign and in malignant thyroid nodules to determine its potential as a biomarker.

Conditions

  • Thyroid Nodule

Interventions

DIAGNOSTIC_TEST

Immunohistochemistry

Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.

Sponsors & Collaborators

  • Robert Day

    lead OTHER

Principal Investigators

  • Robert Day, PhD · Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-01-15
Completion
2018-01-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160482 on ClinicalTrials.gov